Form 4: Century Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Douglas Carr, SVP of Finance & Operations at Century Therapeutics, sold 257 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 3, 2024, Douglas Carr, the SVP of Finance & Operations at Century Therapeutics, sold 257 shares of the company's common stock.
- The sale was executed at a price of $3.106 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Carr directly owns 317,323 shares of Century Therapeutics.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of the stock sale transaction. |
| 05/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.